Recordati Industria Chimica e Farmaceutica SpA
Recordati Industria Chimica e Far.../ IT0003828271 /
REC/M
10/05/2024 15:41:37
|
Diferencia
+0.15
|
Volumen |
Bid15:42:21 |
Ask15:42:26 |
Capitalización de mecado |
Dividendo A. |
P/E Ratio |
50.95EUR
|
+0.30%
|
60,777 Volumen de negocios: 1.12 millones |
50.90Volumen de oferta: 262 |
50.95Tamaño/ Volumen/ Formato de Ask: 402 |
10.51 mil millonesEUR |
2.35% |
26.94 |
Descripción de negocio
Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange, with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa and in the United States of America. An efficient field force of medical representatives promotes a wide range of innovative pharmaceuticals, both proprietary and under license, in a number of therapeutic areas including a specialized business dedicated to treatments for rare diseases. Recordati is a partner of choice for new product licenses for its territories. Recordati is committed to the research and development of new specialties within the urogenital therapeutic area and of treatments for rare diseases.
Consejo de gestión & Consejo de supervisión
CEO |
Robert Koremans |
Consejo de gestión |
Andrea Recordati, Giampiero Mazza, Guido Guidi, Joanna Le Couilliard, Michaela Castelli, Piergiorgio Peluso, Cathrin Petty, Giorgio De Palma, Elisa Corghi, Luigi La Corte, Kim Stratton |
Consejo de supervisión |
Antonio Santi, Andrea Balelli, Ezio Simonelli, Livia Amidani Aliberti, Patrizia Oriundi Paleologo, Emiliano Nitti , Marco Antonio Viganò |
Datos de la empresa
Nombre: |
Recordati S.p.A. |
Dirección: |
via M. Civitali 1,I-20148 Milano |
Teléfono: |
+39-02-48787-1 |
Fax: |
+39-02-40073-747 |
E-mail: |
-
|
Internet: |
www.recordati.com/ |
Industria: |
Healthcare |
Sector: |
Pharmaceutical Industry |
Subsector: |
Pharmaceuticals |
Fin del año financiero: |
31/12 |
Acciones de libre circulación: |
46.40% |
Fecha de OPI: |
01/01/1984 |
Relación con inversores
Nombre: |
Marianne Tatschke |
IR teléfono: |
- |
IR-fax: |
+39-02-48787-225 |
IR e-mail: |
inver@recordati.it
|
Calendario de la empresa
CW 21 | 20/05/2024
Ex-Dividend
|
CW 21 | 21/05/2024
Record Date
|
CW 21 | 22/05/2024
Dividend Payment
|
CW 31 | 30/07/2024
Interim Report 2nd Quarter/6 Months
|
CW 45 | 08/11/2024
Interim Report 3rd Quarter/9 Months
|